We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Corporate
Cell Culture Media Suppliers: Regulatory Considerations for Advanced Therapies
What are the regulatory challenges and opportunities that exist in media production for cell and gene therapies? In this webinar, Marlin Frechette, Corporate Read more...Regulatory Considerations for Raw Material Quality and Testing
What are the regulations and requirements that raw material suppliers need to understand to develop commercially viable advanced therapies? In a discussion led by Read more...BioInformant Goes Behind the Scenes at FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific CEO Yutaka Yamaguchi interviewed by Bioinformant
Yutaka Yamaguchi, CEO of FUJIFILM Irvine Scientific, was recently invited to sit down Read more...Leading Industry Experts Address Cell and Gene Therapy Raw Materials Supply Chain Needs
Recently Marlin Frechette, FUJIFILM Irvine Scientific's Sr. Director of Quality Systems/Regulatory Affairs/Compliance Officer & ISO Management Representative, Read more...Cell Culture Experts Share Insights and Look into the Future of Media Development
Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific recently participated in a panel discussion among cell culture media experts about current Read more...First Annual Walk of Hope 5K Raises Funds to Help Patients with Infertility
Hope is what keeps dreams alive and what sustains patients battling infertility through their arduous IVF journey to see their dream of a family realized. On August Read more...Go from Good Enough to Optimal Cell Culture Media
Not all cell lines are created equal—and neither is their associated media.
To achieve the desired target performance, the design and development of an optimal Read more...Quality Media by Design
Current Good Manufacturing Practices (cGMP) guidelines are regulations provided by the United States Food and Drug Administration (FDA) to ensure the safety and Read more...
Recent Posts
-
Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges -
Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation -
How Monoclonal Antibodies Have Transformed Breast Cancer Treatment, and Where is it Going Next -
Meet the Team: Interview with Brandon Pence – President and Chief Operating Officer -
Meet the Team: Interview with Robert Hodge – Senior Director, Corporate Planning
